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Abstract
Background: There is a wealth of evidence regarding the detrimental impact of excessive alcohol
consumption. In older populations excessive alcohol consumption is associated with increased risk
of coronary heart disease, hypertension, stroke and a range of cancers. Alcohol consumption is also
associated with an increased risk of falls, early onset of dementia and other cognitive deficits.
Physiological changes that occur as part of the ageing process mean that older people experience
alcohol related problems at lower consumption levels. There is a strong evidence base for the
effectiveness of brief psychosocial interventions in reducing alcohol consumption in populations
identified opportunistically in primary care settings. Stepped care interventions involve the delivery
of more intensive interventions only to those in the population who fail to respond to less intensive
interventions and provide a potentially resource efficient means of meeting the needs of this
population.
Methods/design: The study design is a pragmatic prospective multi-centre two arm randomised
controlled trial. The primary hypothesis is that stepped care interventions for older hazardous
alcohol users reduce alcohol consumption compared with a minimal intervention at 12 months
post randomisation. Potential participants are identified using the AUDIT questionnaire. Eligible and
consenting participants are randomised with equal probability to either a minimal intervention or
a three step treatment approach. The step treatment approach incorporates as step 1 behavioural
change counselling, step 2 three sessions of motivational enhancement therapy and step 3 referral
to specialist services. The primary outcome is measured using average standard drinks per day and
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secondary outcome measures include the Drinking Problems Index, health related quality of life and
health utility. The study incorporates a comprehensive economic analysis to assess the relative
cost-effectiveness of the interventions.
Discussion: The paper presents a protocol for the first pragmatic randomised controlled trial
evaluating the effectiveness and cost-effectiveness of stepped care interventions for older
hazardous alcohol users in primary care.
Trial registration: ISRCTN52557360
Background
There exists a wealth of evidence regarding the detrimen-
tal impact of hazardous alcohol consumption, consuming
more than the weekly recommended number of standard
alcohol units in any week (21 for males, 14 for females)
or half of the recommended number of standard alcohol
units in any one day (10 for males, 7 for females), on the
physical and mental health of the population. It is esti-
mated that hazardous alcohol consumption accounts for
150000 hospital admissions and between 15000 and
22000 deaths per annum in the United Kingdom [1]. In
the older population, those aged 55 years or more, haz-
ardous alcohol consumption is associated with a wide
range of physical, psychological and social problems.
There is evidence of an association between increased
alcohol consumption and increased risk of coronary heart
disease, hypertension, haemorrhagic and ischemic stroke,
increased rates of alcohol-related liver disease and
increased risk of a range of cancers [2]. Alcohol consump-
tion is identified as one of the three main risk factors for
falls [3], a major cause of morbidity and mortality in this
population. The Royal College of Physicians estimates
that 60% of older people admitted to hospital because of
repeated falls, confusion, chest infections and heart failure
have undiagnosed alcohol problems [4]. Increased alco-
hol consumption in older age can also contribute to the
onset of dementia and other age related cognitive deficits,
Parkinson's disease and a range of psychological prob-
lems including depression and anxiety [5]. Alcohol use is
implicated in one third of all suicides in the older popula-
tion [6]. It is estimated that 80% of those aged 65 and over
regularly take prescribed medication and polypharmacy is
common with a third taking at least four prescribed med-
ications per day [7]. Alcohol is a major contraindication
for many of the drugs prescribed for older people and
alcohol and medication interactions are a common phe-
nomenon. Increased alcohol consumption in older age is
also associated with a range of social problems including
self-neglect, poor nutrition, social isolation and hypother-
mia [8].
The prevalence of hazardous alcohol consumption, this is
inclusive of harmful consumption, in those aged 55 years
and over is generally lower than the general population.
The most recent estimate derived from the Alcohol Needs
Assessment research Project [9] indicates a prevalence of
between 15% and 25% and concurs with other estimates
derived from the General Household Survey. There is also
evidence that the prevalence rate in primary care attendees
is higher than the general population [10]. There is evi-
dence that these prevalence rates are under-estimates of
the true prevalence rate. Older people are less likely to
seek treatment for alcohol use disorders [11] and alcohol
related presentations are often atypical or masked by
comorbid physical or psychiatric illness that makes alco-
hol related diagnosis more difficult [12]. In 2000 16% of
the UK population was over the age of 65 and this is
expected to increase to 21% by 2026 [7]. As the average
age of the population increases the absolute number of
older people consuming alcohol at hazardous levels will
increase even if the prevalence rate remains stable. Recent
research using data derived from the General Practice
Research Database indicates that only 5% of people aged
55 years or older with an alcohol use disorder are identi-
fied in primary care settings [13]. Opportunistic screening
is a proactive screening technique that has been used with
some success in a variety of healthcare areas including
type II diabetes and Chlamydia [14] and is particularly
useful in identifying conditions in populations who
would not usually seek treatment.
A number of paper based screening methods have been
developed to identify hazardous alcohol consumption;
these include instruments such as the Michigan Alcohol
Screening Test [15], Paddington Alcohol Test [16], Fast
Alcohol Screening Test [17] and the Alcohol Use Disor-
ders Identification Test [18]. All have acceptable levels of
sensitivity and specificity. The Alcohol Use Disorders
Identification Test (AUDIT) was specifically developed for
use in a primary care population and has 92% sensitivity
and 92% specificity for identifying hazardous alcohol use
in a UK primary care setting [10]; more specifically in
older populations AUDIT has been demonstrated to have
higher sensitivity, 75%, and higher specificity, 97.2% than
other screening tests when used in older populations [19].
AUDIT is a short 10-item questionnaire that addresses fre-
quency of alcohol consumption, alcohol related prob-
lems and alcohol dependence symptoms. Because of theBMC Health Services Research 2008, 8:129 http://www.biomedcentral.com/1472-6963/8/129
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evidence of under detection and misdiagnosis of hazard-
ous alcohol use in older populations [11,12] the proactive
application of a short universal screening method is likely
to be more appropriate. There is evidence that patients are
more compliant with screening protocols for alcohol use
in healthcare settings and that the environment provides
an opportunity for a 'teachable moment' increasing the
patient's likelihood to engage in an intervention [20].
There is a substantial evidence base for the efficacy of brief
motivational interventions, aimed at reducing alcohol
consumption in primary care. Studies have demonstrated
the effectiveness of brief interventions in reducing alcohol
consumption in primary care populations in the United
Kingdom [21]. Further, there are six systematic reviews
focusing specifically upon the effectiveness of brief inter-
ventions in primary care populations [22-27] all conclude
that brief interventions in primary care populations are
effective in reducing alcohol consumption. But many of
the studies included in these reviews exclude older
patients. There are no systematic reviews or subgroup
analyses specifically focussing on older patient groups.
There is some evidence from primary research of the effi-
cacy of brief interventions specifically for older hazardous
alcohol consumers. In a trial of brief interventions for
older alcohol users in primary care in the United States,
Fleming et al [28] reported a 34% reduction in alcohol
consumption and 64% reduction in those drinking at haz-
ardous levels at 12 months, significantly better than those
who received no intervention. Blow and Barry [29] also
report significantly greater reduction in alcohol use in
older populations treated with brief interventions in pri-
mary care than controls. There is also evidence from sub-
group analyses of existing studies that older patients are at
least as likely to benefit from brief interventions as
younger patients [30] and older adults are more likely to
adhere and comply with brief intervention treatment
regimes [31]. While a number of brief intervention studies
have addressed the issue of cost-effectiveness, few have
addressed the issue from a pragmatic NHS perspective.
The evidence of brief interventions has been criticised for
failing to address a wider range of alcohol use disorders
including harmful alcohol consumption [32] and for fail-
ing to address more entrenched drinking behaviours.
Screening for alcohol use disorders identifies a range of
needs that are likely to require a range of types and inten-
sities of intervention. One of the primary reasons why
many general practitioners are reluctant to implement
screening into routine care is because they lack the skills
of how to deal with the more severe cases identified. Moti-
vational Enhancement Therapy is a relatively short, usu-
ally three 40 minute sessions delivered by a trained
therapist, but more intensive intervention than a brief
motivational intervention. Primary research has shown it
to be as effective as other more intensive interventions
such as cognitive behavioural therapy, twelve steps facili-
tation therapy and social behavioural network therapy
[33,34].
Older alcohol consumers are often typified as either 'early
onset' drinkers, whose consumption pattern is a continu-
ation of lifetime hazardous consumption or 'late onset'
drinkers whose alcohol consumption is a reaction to life
events occurring in later life. 'Late onset' drinkers' are
more likely to benefit from brief interventions than 'early
onset' drinkers who often require a more intensive inter-
vention approach [35]. Physiological changes that occur
as part of the ageing process mean that older people are
more vulnerable to alcohol and experience alcohol related
problems at lower consumption levels than younger peo-
ple. Stepped care interventions offer a potentially resource
efficient means of meeting the needs of this population.
Stepped care interventions provide a means of delivering
more intensive interventions only to those who fail to
respond to less intensive interventions and are more in
keeping with rational clinical decision making than the
blanket use of any one intervention strategy.
Aims of the study
1. To evaluate the effectiveness of stepped care interven-
tions for older hazardous alcohol users in primary care.
2. To evaluate the cost-effectiveness of stepped care inter-
ventions for older hazardous alcohol users in primary
care.
3. To screen 4170 primary care attendees aged 55 years or
more for hazardous alcohol use using the AUDIT ques-
tionnaire.
4. To evaluate the acceptability and validity of opportun-
istically screening for hazardous alcohol use in older pri-
mary care attendees.
5. To estimate the prevalence of alcohol use disorders in
an older primary care population.
6. To train 15 practice nurses in the delivery of behav-
ioural change counselling.
7. To conduct a pragmatic randomised controlled trial
comparing stepped care interventions with a minimal
intervention for older hazardous alcohol users in primary
care.
8. To randomise 500 hazardous alcohol users, with equal
probability, to either a minimal intervention or stepped
care.BMC Health Services Research 2008, 8:129 http://www.biomedcentral.com/1472-6963/8/129
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9. To conduct 6 and 12 month follow ups on at least 70%
of those randomised to assess alcohol consumption, alco-
hol related problems, quality of life and service utilisa-
tion.
10. To study the process of therapy as delivered by both
practice nurses and trained therapists.
Methods/design
The study is a pragmatic parallel group randomised con-
trolled trial. The study has been granted ethical approval
by the North West Multi-Centre Research Ethics Commit-
tee ref: 07/MRE08/24. The study complies with the Hel-
sinki Declaration. A full flow diagram for the study is
shown in figure 1.
Hypothesis
Primary hypothesis
Stepped care interventions for older hazardous alcohol
users reduce alcohol consumption compared with a min-
imal intervention 12 months after the intervention.
Secondary hypotheses
Stepped care is more cost-effective than minimal interven-
tion. Stepped care will reduce alcohol related problems in
the 12 months after intervention in comparison to mini-
mal intervention. Stepped care will increase health related
quality of life in the 12 months after intervention com-
pared with minimal intervention.
Trial inclusion/exclusion criteria
Inclusion and exclusion criteria have been chosen to
maintain a balance between ensuring the sample is repre-
sentative of the primary care population whilst ensuring
that the trial population are able to engage both with the
interventions and follow up.
Inclusion criteria
1. Age 55 years or over at time of screening. 2. Diagnosis
of an alcohol use disorder using AUDIT criteria. 3. Resid-
ing in a stable place of residence. 4. Living within com-
mutable distance of the primary care practice. 5. Providing
informed consent for randomisation, treatment and fol-
low up.
Exclusion criteria
1. Treatment for substance use in the past 90 days, exclud-
ing nicotine. 2. Already seeking help for an alcohol use
disorder. 3. Received treatment for primary drug depend-
ence, excluding nicotine in the past 90 days. 4. Outstand-
ing legal issues likely to lead to imprisonment. 5. Severe
mental or physical illness likely to preclude active partici-
pation in treatment or follow up.
Randomisation and consent
Screening
In accordance with guidance on best practice, all attendees
at primary care who are aged 55 years or more will be
informed that a study is taking place. They will be pro-
vided with an information letter and a copy of the AUDIT
questionnaire. The information letter will provide details
of the study taking place and make clear that completion
of the screening questionnaire is not compulsory. Partici-
pants will have the option to not complete the question-
naire, to complete the questionnaire anonymously or
complete the questionnaire with full contact details.
Completed questionnaires will be returned to the practice
in sealed envelopes or directly to the study co-ordinating
centre in York.
Invitation to attend practice nurse assessment
For all AUDIT positives who complete their contact details
and wish to take part in the study, a standard baseline
assessment will be completed with all information
recorded on forms containing only an identification
number. Interested patients will be telephoned by the
practice nurse and an appointment made for them to
attend the practice. A detailed information sheet provid-
ing information on the purpose of the study, the proposed
interventions and follow up assessments will be sent to
the potential participant, stating that participation is not
compulsory.
Baseline assessments
At the assessment the practice nurse will discuss the study,
providing the potential participant with an opportunity to
ask any questions about participation in the study, and
assess further eligibility. Eligible participants will be
invited to provide written informed consent. For those
who do consent, randomisation will be conducted using
the secure remote randomisation service at York Trials
Unit. At this point the patients contact details and identi-
fication number will be associated and held on a secure
server located at the University of York. This master regis-
ter will be held separate from the outcome data and acces-
sible only to those who need to know for purposes of
conducting the study. Randomisation will be conducted
using block randomisation stratified by cluster with an
equal probability of receiving stepped care or minimal
intervention.
Interventions
Screening
All primary care attendees, aged 55 years or older, will be
provided with an information letter, a copy of the AUDIT
questionnaire and a return envelope addressed to the
study co-ordinating centre. Returned questionnaires,
enclosed in a sealed envelope, will be scored by the prac-
tice nurse by summing the responses to all 10 questionsBMC Health Services Research 2008, 8:129 http://www.biomedcentral.com/1472-6963/8/129
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Trial Flow Chart Figure 1
Trial Flow Chart.
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on the AUDIT questionnaire, or returned directly to the
co-ordinating centre for scoring. Patients who score 8 or
more on the AUDIT questionnaire, who are willing to be
contacted and complete a baseline assessment will be
invited to a research assessment with the practice nurse. At
the research assessment the research nurse will explain the
study, provide an opportunity to ask any questions and
ask the potential participant for informed consent. The
research assessment will include a check on eligibility. If
consenting, the patient will be randomised using a remote
randomisation service, with equal probability to either
minimal intervention or stepped care.
Minimal Intervention
The minimal intervention consists of a short, 5 minute,
discussion with the practice nurse about the health conse-
quences of continued hazardous alcohol consumption.
The participant will also receive a brief self-help leaflet
'Safer drinking – a self help guide' outlining the conse-
quences of excessive alcohol consumption and providing
information on sources of help for drinking problems
locally and nationally.
Stepped Care Intervention
The stepped care intervention consists of three consecu-
tive steps in which progression between steps are depend-
ent upon the outcome of each previous step.
Step 1 will consist of a 20 minute session of behavioural
change counselling delivered by the practice nurse. This
intervention, based upon an existing evidence base of
brief interventions, utilises the technique of motivational
interviewing [32] and aims to address the individual's
motivation to change their drinking behaviour. The coun-
selling is manual guided and practice nurses will be
trained in the delivery. Four weeks after the step 1 assess-
ment the participant will be contacted by the practice
nurse and a short telephone assessment will be made
about the participant's alcohol consumption in the past 4
weeks using the extended AUDIT-C. If the participant is
still consuming alcohol at hazardous levels a referral will
be made to step 2 of the intervention.
Step 2 involves an intervention by a trained alcohol ther-
apist in the primary care environment. The intervention,
Motivational Enhancement Therapy, is provided through
three, 40 minute sessions on a weekly basis. The interven-
tion is manual guided and addresses six basic principles of
increasing motivation for change. Feedback about indi-
vidual alcohol consumption, emphasis on the individual
as being the agent responsible to change, advice on how
to accomplish change, provision of alternative vehicles for
change, maintenance of an empathetic therapeutic style
and emphasis on enhancing the individuals self-efficacy.
Four weeks after the last MET session the participant will
be contacted by the practice nurse and a short telephone
assessment will be made about the participant's alcohol
consumption in the past 4 weeks using the extended
AUDIT-C. If the participant is still consuming alcohol at
hazardous levels a referral will be made to step 3 of the
intervention.
Step 3 will consist of a referral to the local specialist alco-
hol services to receive specialist intervention, including as
necessary detoxification, inpatient care, outpatient coun-
selling, group therapy, relapse prevention treatment or
medication. There is no limit on the intensity or duration
of the step 3 intervention.
Particular emphasis is being paid to ensure that the inter-
ventions are pragmatic in nature. The interventions will
be delivered by staff routinely employed in primary care,
in the case of practice nurses, and specialist alcohol serv-
ices in the case of motivational enhancement therapists.
All of the interventions will be manual guided to specify
the purpose and principles of each intervention and the
structure and content of each particular treatment session.
Training of practice nurses to deliver behavioural change intervention
It is proposed to train 15 practice nurses in the techniques
and delivery of a brief motivational behavioural change
intervention. Each practice nurse will spend 2 days at the
training centre at Leeds Addiction Unit. Training will be
provided by expert trainers in motivational interviewing.
The training will take the form of simulated consultation/
seminar/simulated consultation. Each nurse will have the
opportunity to engage in a simulated consultation which
is recorded. As a group the nurses will discuss the simu-
lated consultations to examine and review application of
motivational interviewing techniques. Prior to embarking
on the study assessment of competency will be made
using a recorded session rated by an independent expert.
Practice nurses will be provided with ongoing supervision
throughout the study provided by an expert trainer from
Leeds Addiction Unit. A further training day is provided
covering protocol issues and use of the study database.
Training of therapists to deliver Motivational Enhancement therapy
It is proposed to train alcohol therapists from local alco-
hol agencies. Therapists will have at least two years post-
qualifying experience. Initial training will involve a three
day intensive group training course provide by motiva-
tional enhancement trainers at Leeds Addiction Unit. Par-
ticular attention will be given to understanding the
evidence base, understanding the theoretical basis of
treatment, demonstration of practice and role-play oppor-
tunities. Therapists will be supervised in the delivery of a
number of therapy sessions. Therapists will be expected to
complete two taped sessions both reviewed in conjunc-
tion with a trained supervisor. Supervision will provideBMC Health Services Research 2008, 8:129 http://www.biomedcentral.com/1472-6963/8/129
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the main opportunity for practising skills and delivering
the structure and content of treatment. Assessment of
competence will depend upon the therapist's ability to
deliver motivational enhancement therapy according to
the designation of treatment prescribed in the treatment
manual.
Outcome measures
Screening
Screening for alcohol use disorders will be conducted
using the Alcohol Use Disorders Identification Test
(AUDIT) [18]. The instrument addresses alcohol con-
sumption frequency and quantity, alcohol related prob-
lems and elements of alcohol dependence. The 10-item
patient completed questionnaire takes approximately 3
minutes to complete and 2 minutes to score. A score of 8
or more indicates hazardous alcohol use. AUDIT exhibits
high levels of sensitivity (92%) and specificity (92%) in
UK primary care populations [10] and high levels of sen-
sitivity (75%) and specificity (93%) in older populations
[19].
Eligibility assessment
To establish eligibility a potential participant should score
positive for the AUDIT questionnaire and be classified as
a hazardous alcohol user using extended AUDIT-C crite-
ria. Hazardous alcohol consumption is established if the
participant has consumed more than 21 standard units for
males, or 14 for females, in any one week or 10 standard
units for males or 7 standard units for females in any 1 day
in the previous 90 days. The extended AUDIT-C is used to
derive the primary outcome measure for the study.
Primary outcome measure
The primary outcome measure for the study is average
drinks per day, where a standard drink equates to 8 mg of
ethanol. This is ascertained using the extended AUDIT-C.
Three other variables can be derived from the data; per-
cent days abstinent, drinks per drinking day and total
alcohol consumed. The extended AUDIT-C is self-com-
pleted and takes approximately 2 minutes to complete.
The outcome is measured at baseline, 6 months post ran-
domisation and 12 months post-randomisation.
Secondary outcome measures
1. Alcohol related problems measured at baseline, 6
months and 12 months post randomisation. Alcohol
related problems are assessed using the 17-item partici-
pant completed Drinking Problems Index (DPI). The DPI
has been specifically designed and validated for use in
older populations [36]. 2. Quality of life is measured at
baseline, 6 months and 12 months post randomisation.
Quality of life is measured using the SF-12 [37]. SF-12 is a
12-item self completed questionnaire that established
validity and reliability for measuring physical health and
mental health components of quality of life. 3. Health
utility will be measured at baseline, 6 months and 12
months using the EQ-5D [38]. EQ-5D is a 5-item partici-
pant completed questionnaire with established reliability
and validity in this population.
Economic outcome measures
Opportunistic screening costs will be estimated from the
actual costs of screening using the actual costs of screening
associated with the study. Costs of delivering the minimal
intervention and the first two tiers of stepped care will be
based upon actual patient contact time from time sheets
maintained by practice nurses and therapists. The units of
services used will be based upon local costs of services and
include allowances for managerial and premises over-
heads and the costs associated with training and supervi-
sion using methods utilised in similar intervention
studies [39]. The costs of any specialist referral will be
ascertained using information on the actual costs associ-
ated with specialist service provision based upon Depart-
ment of Health costs of specialist interventions [40].
Participant use of health services, other alcohol services
outside the study, public services and criminal justice serv-
ices will be assessed using a service use questionnaire at
baseline, 6 months and 12 months post randomisation.
The service use questionnaire has been developed over a
number of alcohol intervention studies [39,41] will be
adapted to capture costs specifically associated with this
population.
Quality assurance of treatment delivery
Participants will be asked to provide consent to have all
treatment sessions tape recorded. A 20% sample of each
type of treatment session, minimal intervention, behav-
ioural change intervention, motivational enhancement
therapy will be randomly selected stratified by treatment
type. Tapes will be rated by an independent rater and
assessed for quality of delivery and compliance with treat-
ment protocols.
Sample size calculation
There are no previous studies of stepped care interven-
tions, a brief opportunistic intervention followed by suc-
cessively more intensive interventions for those who fail
to respond to treatment, for older alcohol using adults.
The closest UK pragmatic randomised controlled trials
include Wallace et al [21] and STEPWICE [41], both of
these reported effect size differences between stepped care
and minimal intervention of 0.36 and 0.27 respectively.
Similar effect size differences are reported in studies from
the United States [29,42,43]. There is evidence that older
populations respond as well, or even better, to brief psy-
chosocial interventions for alcohol use than general pop-
ulations [31,44]. Assuming a conservative effect size
difference between stepped care and minimal interven-BMC Health Services Research 2008, 8:129 http://www.biomedcentral.com/1472-6963/8/129
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tion of the order of 0.3 would require a sample size of 175
participants in each of the two randomised groups, using
power at 80% and a 5% significance level.
Our previous experience in conducting randomised con-
trolled trials in the fields of substance use, alcohol using
populations [34,41] and elderly populations indicate that
with assiduous follow up regimes loss to follow up at 12
months is of the order of 20%. There also exists evidence
that older populations are more compliant with treatment
regimes and follow up protocols than younger popula-
tions [45]. Taking these factors into account we have erred
on the side of caution and allowed a loss to follow up of
30%, requiring 500 participants to be randomised, 250 in
each group. Previous alcohol use screening and interven-
tion studies conducted in UK healthcare settings [46] sug-
gest that 80% of those screened positive tend to be eligible
and 75% of those eligible tend to consent to randomisa-
tion. This means the study requires 834 screen positives of
whom we predict 500 will be eligible and consent to ran-
domisation.
The prevalence of hazardous alcohol consumption, inclu-
sive of harmful consumption, in those aged 55 years or
older is estimated at 15% in the general population [9]
and greater, at 25%, in those attending primary care [10].
If we conservatively estimate the prevalence at 20% we
would need to screen 4170 primary care attendees in an
18 month period. Assuming 15 practices, in three geo-
graphic regions consent to take part in the study, each
practice would be expected to screen 278 primary care
attendees over 18 months, a total of 18 per practice per
month.
Statistical analysis
Opportunistic screening
We will use a comprehensive cohort approach to the anal-
ysis of the acceptability and validity of opportunistic
screening. Participants will have a choice of not complet-
ing the questionnaire, completing the questionnaire with
basic age/sex demographics or completing the question-
naire with full contact details.
Effectiveness analysis
The primary analysis will be intention to treat comparing
minimal intervention with stepped care on the primary
outcome measure, average drinks per day, at 12 months
post-randomisation. Participants will be analysed as part
of the group allocated irrespective of treatment received.
The primary outcome will be analysed using analysis of
covariance controlling for baseline values. Multi-level
modelling analysis will be undertaken to account for any
variation due to centre, cluster and therapist. Primary
analysis will be conducted after all 12 month follow ups
have been completed. Analysis of secondary outcomes
will be conducted using analysis of covariance and
adjusted using multi-level modelling. Regression analysis
will be undertaken to explore any baseline predictors of
outcome, any baseline predictors of referral to step 2 for
the stepped care group and any potential baseline × treat-
ment interaction effects.
Economic analysis
The incremental cost-effectiveness of stepped care com-
pared to the minimal intervention will be assessed both
from a health and personal social services perspective fol-
lowing NICE guidance [47] and a wider public sector
resource perspective [48]. While the opportunistic screen-
ing costs will be common to both intervention arms, its
cost will be estimated from the trial data as this would
form part of a wider implementation cost of the stepped
care programme. The costs of the minimal intervention
and the first two tiers of the stepped care programme will
be based on information gathered on patient contact with
the primary care and specialist services during the trial.
The units of service used will be based on the local costs
of specialist services and include an allowance for the
training and supervision costs, using methods developed
for the UKATT trial [39]. Utilisation of more specialist
services will be collected, including the type of interven-
tion, and costs will be applied from previous research tri-
als and a current Department of Health funded research
project based on a range of specialist providers and inter-
vention types [40]. The use of alcohol services outside the
trial protocol, along with all other public sector services,
including health, social welfare and contact with criminal
justice agencies will be assessed from questionnaires
administered at baseline, 6 and 12 months. This service
use questionnaire was developed over a number of alco-
hol and illicit drug trials and has been adapted for the spe-
cific needs of this project, for example, by including
additional questions on falls. Units of resource use
recorded will be combined with national sources of unit
costs [49,39] which will provide generalisable results. The
EQ-5D will be used with population values and the QALY
change calculated using the area under the curve method
[50]. Bootstrapping methods will be used to test to
explore the sensitivity of the calculated incremental cost-
effectiveness ratios and cost-acceptability curves presented
[51].
Frequency of analysis
Analysis will be conducted after the final 12 month follow
up has been completed.
Ethics and confidentiality
The study has been granted ethical approval by multi-cen-
tres research ethics committee and by the local research
ethics committee for the localities where the research will
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either treatment. There is no documented evidence of
adverse events arising due to either the minimal interven-
tion or the stepped care intervention.
All trial data will be identified using a unique trial identi-
fication number. No personally identifiable information
will be held beyond the final 12 month follow up. Analyt-
ical datasets will not contain any patient identifiable
information. Anonymised data will be retained for a
period of 42 months.
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